UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

The American journal of pathology, 1991-05, Vol.138 (5), p.1059-1067

1991

Volltextzugriff (PDF)

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

BMJ, 1998-03, Vol.316 (7134), p.829-830

International edition, 1998

Volltextzugriff (PDF)

Plasminogen Activators, Tissue Degradation, and Cancer

Advances in Cancer Research, 1985, Vol.44, p.139-266

1985

Volltextzugriff (PDF)

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

The American journal of pathology, 1991-01, Vol.138 (1), p.111-117

1991

Volltextzugriff (PDF)

Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients

European journal of cancer (1990), 1997-05, Vol.33 (6), p.867-872

1997

Volltextzugriff (PDF)

Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix

The American journal of pathology, 1989-10, Vol.135 (4), p.631-636

1989

Volltextzugriff (PDF)

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Breast cancer research and treatment, 1998, Vol.47 (1), p.9-16

1998

Volltextzugriff (PDF)

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

Breast cancer research and treatment, 1995-03, Vol.33 (3), p.199-207

1995

Volltextzugriff (PDF)

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop

European journal of cancer (1990), 1996-07, Vol.32 (8), p.1371-1381

1996

Volltextzugriff (PDF)

Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients

Clinical cancer research, 1997-02, Vol.3 (2), p.233-239

1997

Volltextzugriff (PDF)

Indirect Enzyme-linked Immunosorbent Assay for Detection of Antibodies to Actinobacillus Pleuropneumoniae Serovar 7 in Pig Serum

Journal of veterinary diagnostic investigation, 2007-05, Vol.19 (3), p.244-249

2007

Volltextzugriff (PDF)

Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay

British journal of cancer, 1990-03, Vol.61 (3), p.412-414

1990

Volltextzugriff (PDF)

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

The Journal of biological chemistry, 1986-06, Vol.261 (17), p.7644-7651

1986

Volltextzugriff (PDF)

Immunocytochemical Demonstration of Tissue-Type Plasminogen Activator in Endocrine Cells of the Rat Pituitary Gland

The Journal of cell biology, 1985-07, Vol.101 (1), p.305-311

1985

Volltextzugriff (PDF)

Inactive proenzyme to tissue‐type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody

The EMBO journal, 1984-01, Vol.3 (1), p.51-56

1984

Volltextzugriff (PDF)

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

Cancer research (Chicago, Ill.), 1994-09, Vol.54 (17), p.4671-4675

1994

Volltextzugriff (PDF)

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer

The Journal of pathology, 2001-09, Vol.195 (2), p.236-243

2001

Volltextzugriff (PDF)

Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma

Cancer research (Chicago, Ill.), 1994-01, Vol.54 (1), p.120-123

1994

Volltextzugriff (PDF)

Human endothelial cells contain one type of plasminogen activator

FEBS letters, 1984-03, Vol.168 (1), p.33-37

1984

Volltextzugriff (PDF)

Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification

Thrombosis and haemostasis, 1986-04, Vol.55 (2), p.206-212

1986

Volltextzugriff (PDF)

Distribution of Urokinase-Type Plasminogen Activator Immunoreactivity in the Mouse

The Journal of cell biology, 1984-03, Vol.98 (3), p.894-903

1984

Volltextzugriff (PDF)

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

Breast cancer research and treatment, 1993-01, Vol.28 (3), p.223-229

1993

Volltextzugriff (PDF)

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria

British journal of haematology, 1995-03, Vol.89 (3), p.576-581

1995

Volltextzugriff (PDF)

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

Cancer research (Chicago, Ill.), 1993-06, Vol.53 (11), p.2513-2521

1993

Volltextzugriff (PDF)

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

Cancer treatment and research, 1994, Vol.71, p.299

1994

Volltextzugriff (PDF)

1 – 25 von 58

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(49)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(58)

Sprache

Englisch
(58)

Erscheinungsjahr

n.n

Thema

Humans
(37)
Life Sciences & Biomedicine
(37)
Science & Technology
(37)
Biological And Medical Sciences
(34)
Medical Sciences
(25)
Female
(20)
Enzyme-Linked Immunosorbent Assay
(18)
Oncology
(17)
Urokinase-Type Plasminogen Activator - Metabolism
(15)
Prognosis
(13)
Tumors
(13)
Animals
(12)
Urokinase-Type Plasminogen Activator - Analysis
(12)
Adult
(10)
Aged
(10)
Gynecology. Andrology. Obstetrics
(10)
Mammary Gland Diseases
(10)
Middle Aged
(10)
Plasminogen Activators - Metabolism
(10)
Receptors, Urokinase Plasminogen Activator
(10)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas

Association between plasma concentrations of plasminogen activator inhibitor-1 and survival in patients with colorectal cancer

Plasminogen Activators, Tissue Degradation, and Cancer

Localization of urokinase-type plasminogen activator in stromal cells in adenocarcinomas of the colon in humans

Elevated plasma levels of urokinase plasminogen activator receptor in non-small cell lung cancer patients

Urokinase-type plasminogen activator in endothelial cells during acute inflammation of the appendix

Low cathepsin D and low plasminogen activator type 1 inhibitor in tumor cytosols defines a group of node negative breast cancer patients with low risk of recurrence

Urokinase receptor in breast cancer tissue extracts. Enzyme-linked immunosorbent assay with a combination of mono- and polyclonal antibodies

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop

Plasminogen activator inhibitor type 1 in cytosolic tumor extracts predicts prognosis in low-risk breast cancer patients

Indirect Enzyme-linked Immunosorbent Assay for Detection of Antibodies to Actinobacillus Pleuropneumoniae Serovar 7 in Pig Serum

Tissue-type plasminogen activator in plasma from breast cancer patients determined by enzyme-linked immunosorbent assay

Plasminogen activator inhibitor from human fibrosarcoma cells binds urokinase-type plasminogen activator, but not its proenzyme

Immunocytochemical Demonstration of Tissue-Type Plasminogen Activator in Endocrine Cells of the Rat Pituitary Gland

Inactive proenzyme to tissue‐type plasminogen activator from human melanoma cells, identified after affinity purification with a monoclonal antibody

Prognostic impact of urokinase, urokinase receptor, and type 1 plasminogen activator inhibitor in squamous and large cell lung cancer tissue

Plasminogen activator inhibitor-1 as a measure of vascular remodelling in breast cancer

Urokinase and plasminogen activator inhibitor type 1 in pulmonary adenocarcinoma

Human endothelial cells contain one type of plasminogen activator

Monoclonal antibodies to human 54,000 molecular weight plasminogen activator inhibitor from fibrosarcoma cells--inhibitor neutralization and one-step affinity purification

Distribution of Urokinase-Type Plasminogen Activator Immunoreactivity in the Mouse

Enzyme-linked immunosorbent assay of urokinase-type plasminogen activator (uPA) in cytosolic extracts of human breast cancer tissue

The receptor for urokinase plasminogen activator is present in plasma from healthy donors and elevated in patients with paroxysmal nocturnal haemoglobinuria

High levels of urokinase-type plasminogen activator and its inhibitor PAI-1 in cytosolic extracts of breast carcinomas are associated with poor prognosis

Urokinase plasminogen activator (uPA) and its type 1 inhibitor (PAI-1): regulators of proteolysis during cancer invasion and prognostic parameters in breast cancer

Suchergebnisse filtern